Physician profile
Mitchell A Baruchin
NPI 1013973916
$4,404.27
in general payments reported to CMS, 2019-2025
33 companies · $479 in 2025
The $479 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $751 · 2020: $189 · 2021: $684 · 2022: $946 · 2023: $953 · 2024: $403 · 2025: $479.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,835.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,834.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $629.80 | 2019-2024 | Repatha |
| Merck Sharp & Dohme LLC | $537.20 | 2021-2025 | Verquvo, Capvaxive, Janumet |
| Heartflow, INC. | $461.39 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $425.76 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $308.46 | 2019-2024 | Eliquis, Camzyos |
| Abbott Laboratories | $277.80 | 2019-2023 | Mitraclip |
| Pfizer INC. | $255.05 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $242.20 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $233.25 | 2019-2023 | Jardiance |
| Medtronic, INC. | $206.57 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $135.00 | 2023 | Opsumit, Uptravi |
| Atricure, INC. | $89.27 | 2023 | |
| Alnylam Pharmaceuticals INC. | $53.50 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $52.11 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $45.00 | 2023 | Lifevest |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lantheus Medical Imaging, INC. | $42.43 | 2023 | Definity |
| Zoll Circulation INC | $42.24 | 2022 | |
| Boston Scientific Corporation | $39.44 | 2020-2022 | |
| Sanofi-Aventis U.S. LLC | $38.52 | 2019 | |
| Inari Medical, INC. | $35.00 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Novo Nordisk INC | $34.71 | 2023-2025 | Wegovy, Rybelsus, Ozempic |
| W. L. Gore & Associates, INC. | $30.26 | 2022 | |
| Amarin Pharma, INC. | $27.61 | 2019 | |
| Philips North America LLC | $19.16 | 2023 | |
| Impulse Dynamics (USA) INC. | $19.15 | 2022 | |
| Altathera Pharmaceuticals LLC | $19.10 | 2025 | Sotalol Hydrochloride |
| Cvrx, INC. | $19.09 | 2024 | Barostim Neo System |
| Scpharmaceuticals INC. | $18.60 | 2023 | |
| Kiniksa Pharmaceuticals International, Plc | $15.83 | 2024 | Arcalyst |
| Glaxosmithkline, LLC. | $14.63 | 2025 | Arexvy, Shingrix |
| Althera Pharmaceuticals LLC | $14.49 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $13.93 | 2019 | |
| Bardy Diagnostics, INC. | $7.72 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Baruchin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.